Indena has announced that its French production site in Tours, France, successfully passed a US FDA inspection, with no FDA-483 issued, as per EIR (Establishment Inspection Report) received from the Center for Food Safety and Applied Nutrition of the FDA. This, says Indena, confirms that the company meets the new requirements mandated by the FDA Food Safety Modernization Act (FSMA).
The inspection involved the entire organisation and focused on manufacturing operations, HACCP, cleaning, recall, complaint and training program and procedures.
“We are pleased with the successful outcome of the FDA inspection,” said François Mairel, Indena Tours plant director. “The audit covered the manufacturing of important products we are selling to our US customer base, like grape seed, olive polyphenolic and ginkgo biloba extracts and further confirms our commitment to giving our customers the highest standards of quality.”
Indena Tours had previously obtained certifications including the GMP Certificate from the French Health Ministry – ANSM, HACCP, ISO 14001, Kosher and Halal.
The inspection involved the entire organisation and focused on manufacturing operations, HACCP, cleaning, recall, complaint and training program and procedures.
“We are pleased with the successful outcome of the FDA inspection,” said François Mairel, Indena Tours plant director. “The audit covered the manufacturing of important products we are selling to our US customer base, like grape seed, olive polyphenolic and ginkgo biloba extracts and further confirms our commitment to giving our customers the highest standards of quality.”
Indena Tours had previously obtained certifications including the GMP Certificate from the French Health Ministry – ANSM, HACCP, ISO 14001, Kosher and Halal.
